Who owns EVELO BIOSCIENCES INC?
- Ticker: EVLO
- CUSIP Number: 299734202
Tip: Access positions for across all investors
Analyze quarterly positions in Evelo Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Evelo Biosciences stock
Who bought or sold EVELO BIOSCIENCES INC this quarter?
There are no current stakeholders of Evelo Biosciences.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Evelo Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Flagship Ventures Management | Sep 2023 | 7.9M | $31M |
| Vanguard Group | Sep 2023 | 358k | $1.4M |
| Alyeska Investment Group | Sep 2023 | 265k | $1.0M |
| Credit Suisse | Sep 2023 | 200k | $784k |
| Alphabet | Sep 2023 | 53k | $208k |
| Millennium Management | Sep 2023 | 38k | $149k |
| Barclays | Sep 2023 | 12k | $46k |
| Jpmorgan Chase & Co | Sep 2023 | 3.2k | $12k |
| Bank of America Corporation | Sep 2023 | 2.8k | $11k |
| Citigroup | Sep 2023 | 1.9k | $7.3k |
| UBS Group | Sep 2023 | 923.00 | $3.6k |
| Royal Bank of Canada | Sep 2023 | 505.00 | $2.0k |
| China Universal Asset Management | Sep 2023 | 477.00 | $2.0k |
| Pnc Financial Services | Sep 2023 | 180.00 | $705.996000 |
| Wells Fargo & Company | Sep 2023 | 52.00 | $204.001200 |
| Larson Financial Group | Sep 2023 | 36.00 | $141.001200 |